Effect of DOPA Decarboxylase Inhibitor Supplements on the Incidence of Urinary Tract Infections in Parkinson’s Disease Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Arch Ital Urol Androl 2024, 96 (4). https://doi.org/10.4081/aiua.2024.12833.